Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Cardiovascular Toxicology
Published in:

04-05-2024 | Research

Betaine Protects Mice from Cardiotoxicity Triggered by Sodium Arsenite Through Antioxidative and Anti-inflammatory Pathways

Authors: Saeedeh Shariati, Maryam Shirani, Reza Azadnasab, Layasadat Khorsandi, Mohammad Javad Khodayar

Published in: Cardiovascular Toxicology | Issue 6/2024

Login to get access

Abstract

NaAsO2 is known as a harmful pollutant all over the world, and many chronic heart diseases can be attributed to its prolonged exposure in NaAsO2-contaminated water. Therefore, considering the anti-inflammatory and antioxidant effects of betaine (BET), in this study, our team investigated the cardioprotective effects of this phytochemical agent on sodium arsenite (NaAsO2)-induced cardiotoxicity. Forty male mice were randomly divided into 4 groups: (I) Control; (II) BET (500 mg/kg); (III) NaAsO2 (50 ppm); and (IV) NaAsO2 + BET. NaAsO2 was given to the animals for 8 weeks, but BET was given in the last two weeks. After decapitation, inflammatory factors and biochemical parameters were measured, and Western blot analyses were performed. BET decrease the activity level of alanine aspartate aminotransferase, creatine kinase MB, thiobarbituric acid reactive substances level, inflammatory factors (tumor necrosis factor-α) content, and nuclear factor kappa B expression. Furthermore, BET increased cardiac total thiol and activity levels of catalase, superoxide dismutase, and glutathione peroxidase and nuclear factor erythroid-2 expression. Hence, the administration of BET ameliorated the deleterious effects stemming from the imbalance of oxidative and antioxidant pathways and histopathological alterations observed in NaAsO2-intoxicated mice, thereby attenuating oxidative stress-induced damage and inflammation.
Literature
1.
Moon, K., Guallar, E., & Navas-Acien, A. (2012). Arsenic exposure and cardiovascular disease: An updated systematic review. Current Atherosclerosis Reports, 14, 542–555.PubMedPubMedCentralCrossRef
2.
Jiang, X., & Yan, M. (2021). Surgical treatment for improved 1-year survival in patients with primary cardiac sarcoma. Anatolian Journal of Cardiology, 25, 796.PubMedPubMedCentralCrossRef
3.
Zhu, Y., Huang, R., Wu, Z., Song, S., Cheng, L., & Zhu, R. (2021). Deep learning-based predictive identification of neural stem cell differentiation. Nature Communications, 12, 2614.PubMedPubMedCentralCrossRef
4.
Xiaolong, J., Jianhang, G., Jingyuan, T., Ke, M., & Yanqi, L. (2023). Research progress on degradation methods and product properties of plant polysaccharides. Journal of Light Industry, 38, 1.
5.
Mumford, J. L., Wu, K., Xia, Y., Kwok, R., Yang, Z., Foster, J., & Sanders, W. E., Jr. (2007). Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environmental Health Perspectives, 115, 690–694.PubMedPubMedCentralCrossRef
6.
Alissa, E. M., & Ferns, G. A. (2011). Heavy metal poisoning and cardiovascular disease. Journal of Toxicology, 2011, 1.CrossRef
7.
Mathews, V., Paul, M., Abhilash, M., Manju, A., Abhilash, S., & Nair, R. H. (2013). Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. European Review in Medicine and Pharmacological Science, 17, 34–38.
8.
Zhou, L., Liu, Y., Sun, H., Li, H., Zhang, Z., & Hao, P. (2022). Usefulness of enzyme-free and enzyme-resistant detection of complement component 5 to evaluate acute myocardial infarction. Sensors and Actuators B: Chemical, 369, 132315.CrossRef
9.
Fu, Q., Chen, R., Ding, Y., Xu, S., Huang, C., He, B., Jiang, T., Zeng, B., Bao, M., & Li, S. (2023). Sodium intake and the risk of various types of cardiovascular diseases: A Mendelian randomization study. Frontiers in Nutrition, 10, 1.CrossRef
10.
Yang, W., Ding, N., Luo, R., Zhang, Q., Li, Z., Zhao, F., Zhang, S., Zhang, X., Zhou, T., & Wang, H. (2023). Exosomes from young healthy human plasma promote functional recovery from intracerebral hemorrhage via counteracting ferroptotic injury. Bioactive Materials, 27, 1–14.PubMedPubMedCentralCrossRef
11.
Yu, Y., Wang, L., Ni, S., Li, D., Liu, J., Chu, H. Y., Zhang, N., Sun, M., Li, N., & Ren, Q. (2022). Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation. Nature Communications, 13, 4241.PubMedPubMedCentralCrossRef
12.
Samanta, J., Mondal, A., Saha, S., Chakraborty, S., & Sengupta, A. (2020). Oleic acid protects from arsenic-induced cardiac hypertrophy via AMPK/FoxO/NFATc3 pathway. Cardiovascular Toxicology, 20, 261–280.PubMedCrossRef
13.
Klaassen, C. D., & Amdur, M. O. (2013). Casarett and Doull’s toxicology: The basic science of poisons. McGraw-Hill.
14.
Moon, K. A., Guallar, E., Umans, J. G., Devereux, R. B., Best, L. G., Francesconi, K. A., Goessler, W., Pollak, J., Silbergeld, E. K., & Howard, B. V. (2013). Association between exposure to low to moderate arsenic levels and incident cardiovascular disease: A prospective cohort study. Annals of Internal Medicine, 159, 649–659.PubMedPubMedCentral
15.
Alamolhodaei, N. S., Shirani, K., & Karimi, G. (2015). Arsenic cardiotoxicity: An overview. Environmental Toxicology and Pharmacology, 40, 1005–1014.PubMedCrossRef
16.
Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C. J., & Valko, M. (2011). Arsenic: Toxicity, oxidative stress and human disease. Journal of Applied Toxicology, 31, 95–107.PubMedCrossRef
17.
Kuzu, M., Kandemir, F. M., Yıldırım, S., Çağlayan, C., & Küçükler, S. (2021). Attenuation of sodium arsenite-induced cardiotoxicity and neurotoxicity with the antioxidant, anti-inflammatory, and antiapoptotic effects of hesperidin. Environmental Science and Pollution Research, 28, 10818–10831.PubMedCrossRef
18.
De Zwart, F., Slow, S., Payne, R., Lever, M., George, P., Gerrard, J., & Chambers, S. (2003). Glycine betaine and glycine betaine analogues in common foods. Food Chemistry, 83, 197–204.CrossRef
19.
Sakamoto, A., Nishimura, Y., Ono, H., & Sakura, N. (2002). Betaine and homocysteine concentrations in foods. Pediatrics International, 44, 409–413.PubMedCrossRef
20.
Craig, S. A. (2004). Betaine in human nutrition. The American Journal of Clinical Nutrition, 80, 539–549.PubMedCrossRef
21.
Alirezaei, M., Jelodar, G., Niknam, P., Ghayemi, Z., & Nazifi, S. (2011). Betaine prevents ethanol-induced oxidative stress and reduces total homocysteine in the rat cerebellum. Journal of Physiology and Biochemistry, 67, 605–612.PubMedCrossRef
22.
Al-Hafyan, S., Asoodeh, A., Baghshani, H., & Salari, L. E. (2023). Ameliorative potential of betaine against arsenite-induced hepatotoxicity and nephrotoxicity. Comparative Clinical Pathology, 1, 1–8.
23.
Jung, Y. S., Kim, S. J., Kwon, D. Y., Ahn, C. W., Kim, Y. S., Choi, D. W., & Kim, Y. C. (2013). Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism. Food and Chemical Toxicology, 62, 292–298.PubMedCrossRef
24.
Day, C. R., & Kempson, S. A. (2016). Betaine chemistry, roles, and potential use in liver disease. Biochimica et Biophysica Acta (BBA)-General Subjects, 1860, 1098–1106.PubMedCrossRef
25.
Murillo-Fuentes, M. L., Artillo, R., Ubeda, N., Varela-Moreiras, G., Murillo, M. L., & Carreras, O. (2005). Hepatic S-adenosylmethionine after maternal alcohol exposure on offspring rats. Addiction Biology, 10, 139–144.PubMedCrossRef
26.
van der Veen, S., Hain, T., Wouters, J. A., Hossain, H., de Vos, W. M., Abee, T., Chakraborty, T., & Wells-Bennik, M. H. (2007). The heat-shock response of Listeria monocytogenes comprises genes involved in heat shock, cell division, cell wall synthesis, and the SOS response. Microbiology, 153, 3593–3607.PubMedCrossRef
27.
Burg, M. B. (1995). Molecular basis of osmotic regulation. American Journal of Physiology-Renal Physiology, 268, F983–F996.CrossRef
28.
Qiu, H., Chen, X., Luo, Z., Zhao, L., Zhang, T., Yang, N., Long, X., Xie, H., Liu, J., & Xu, W. (2018). Inhibition of endogenous hydrogen sulfide production exacerbates the inflammatory response during urine-derived sepsis-induced kidney injury. Experimental and Therapeutic Medicine, 16, 2851–2858.PubMedPubMedCentral
29.
Bao, M.-H., Luo, H.-Q., Chen, L.-H., Tang, L., Ma, K.-F., Xiang, J., Dong, L.-P., Zeng, J., Li, G.-Y., & Li, J.-M. (2016). Impact of high fat diet on long non-coding RNAs and messenger RNAs expression in the aortas of ApoE(−/−) mice. Scientific Reports, 6, 34161.PubMedPubMedCentralCrossRef
30.
Zhou, Y., Sun, X., Yang, G., Ding, N., Pan, X., Zhong, A., Guo, T., Peng, Z., & Chai, X. (2023). Sex-specific differences in the association between steps per day and all-cause mortality among a cohort of adult patients from the United States with congestive heart failure. Heart & Lung, 62, 175–179.CrossRef
31.
Tang, L., Wang, Y., Xiang, J., Yang, D., Zhang, Y., Xiang, Q., & Li, J. (2023). lncRNA and circRNA expression profiles in the hippocampus of Aβ 25–35-induced AD mice treated with tripterygium glycoside. Experimental and Therapeutic Medicine, 26, 1–14.CrossRef
32.
Feng, S., Liu, W., Deng, S., Song, G., Zhou, J., Zheng, Z., & Song, Z. (2022). An atopic dermatitis-like mouse model by alternate epicutaneous application of dinitrofluorobenzene and an extract of dermatophagoides farinae. Frontiers in Medicine, 9, 843230.PubMedPubMedCentralCrossRef
33.
Sternbach, S., & McDonough, J. (2023). Betaine as a neuroprotective therapy in multiple sclerosis (Chapter 24). In C. R. Martin, V. B. Patel, & V. R. Preedy (Eds.), Treatments, nutraceuticals, supplements, and herbal medicine in neurological disorders (pp. 443–452). Academic Press.CrossRef
34.
Ashtary-Larky, D., Bagheri, R., Ghanavati, M., Asbaghi, O., Tinsley, G. M., Mombaini, D., Kooti, W., Kashkooli, S., & Wong, A. (2022). Effects of betaine supplementation on cardiovascular markers: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 62, 6516–6533.PubMedCrossRef
35.
Zhao, G., He, F., Wu, C., Li, P., Li, N., Deng, J., Zhu, G., Ren, W., & Peng, Y. (2018). Betaine in inflammation: Mechanistic aspects and applications. Frontiers in Immunology, 9, 1070.PubMedPubMedCentralCrossRef
36.
Ganesan, B., Buddhan, S., Anandan, R., Sivakumar, R., & AnbinEzhilan, R. (2010). Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. Molecular Biology Reports, 37, 1319–1327.PubMedCrossRef
37.
Wu, M.-M., Chiou, H.-Y., Hsueh, Y.-M., Hong, C.-T., Su, C.-L., Chang, S.-F., Huang, W.-L., Wang, H.-T., Wang, Y.-H., Hsieh, Y.-C., & Chen, C.-J. (2006). Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicology and Applied Pharmacology, 216, 168–175.PubMedCrossRef
38.
Khodayar, M. J., Kalantari, H., Khorsandi, L., Rashno, M., & Zeidooni, L. (2018). Betaine protects mice against acetaminophen hepatotoxicity possibly via mitochondrial complex II and glutathione availability. Biomedicine & Pharmacotherapy, 103, 1436–1445.CrossRef
39.
Dutta, S., Saha, S., Mahalanobish, S., Sadhukhan, P., & Sil, P. C. (2018). Melatonin attenuates arsenic induced nephropathy via the regulation of oxidative stress and inflammatory signaling cascades in mice. Food and Chemical Toxicology, 118, 303–316.PubMedCrossRef
40.
Ogihara, N., & Haley-Vicente, D. (2002). Protein target discovery and characterization-DS modeling and discovery studio streamline target discovery. Genetic Engineering News, 22, 77.
41.
Tissue, E. (1959). Sulfhydryl groups. Archives in Biochemistry and Biophysics, 82, 70–77.CrossRef
42.
Fossati, P., Prencipe, L., & Berti, G. (1980). Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical Chemistry, 26, 227–231.PubMedCrossRef
43.
Shangari, N., & O’Brien, P. J. (2006). Catalase activity assays. Current Protocols in Toxicology, 27, 1–16.CrossRef
44.
45.
Yousuf, R., Verma, P. K., Sharma, P., Sood, S., Aït-Kaddour, A., & Bhat, Z. F. (2023). Ameliorative potential of quercetin and catechin against sodium arsenite and mancozeb-induced oxidative renal damage in Wistar rats. Journal of Trace Elements and Minerals, 1, 100079.CrossRef
46.
Sevim, Ç., Doğan, E., & Comakli, S. (2020). Cardiovascular disease and toxic metals. Current Opinion in Toxicology, 19, 88–92.CrossRef
47.
Bjørklund, G., Oliinyk, P., Lysiuk, R., Rahaman, M. S., Antonyak, H., Lozynska, I., Lenchyk, L., & Peana, M. (2020). Arsenic intoxication: General aspects and chelating agents. Archives of Toxicology, 94, 1879–1897.PubMedPubMedCentralCrossRef
48.
Hauptman, M., & Woolf, A. D. (2022). British anti-lewisite (dimercaprol) (Chapter 34). In A. D. Woolf (Ed.), History of modern clinical toxicology (pp. 243–254). Academic Press.CrossRef
49.
Bhattacharya, S. (2017). Medicinal plants and natural products in amelioration of arsenic toxicity: A short review. Pharmaceutical Biology, 55, 349–354.PubMedCrossRef
50.
Yu, X., Wang, Z., Shu, Z., Li, Z., Ning, Y., Yun, K., Bai, H., Liu, R., & Liu, W. (2017). Effect and mechanism of Sorbus pohuashanensis (Hante) Hedl flavonoids protect against arsenic trioxide-induced cardiotoxicity. Biomedicine & Pharmacotherapy, 88, 1–10.CrossRef
51.
Hosseinzadeh, A., Houshmand, G., Goudarzi, M., Sezavar, S. H., Mehrzadi, S., Mansouri, E., & Kalantar, M. (2019). Ameliorative effect of gallic acid on sodium arsenite-induced spleno-, cardio- and hemato-toxicity in rats. Life Sciences, 217, 91–100.PubMedCrossRef
52.
Manna, P., Sinha, M., & Sil, P. C. (2008). Arsenic-induced oxidative myocardial injury: Protective role of arjunolic acid. Archives of Toxicology, 82, 137–149.PubMedCrossRef
53.
54.
Shi, H., Shi, X., & Liu, K. J. (2004). Oxidative mechanism of arsenic toxicity and carcinogenesis. Molecular and Cellular Biochemistry, 255, 67–78.PubMedCrossRef
55.
Roth, R., & JH, L.J. (2019). Casarett & Doull’s toxicology: The basic science of poisons. McGraw-Hill Education.
56.
Gamble, M. V., Liu, X., Ahsan, H., Pilsner, J. R., Ilievski, V., Slavkovich, V., Parvez, F., Levy, D., Factor-Litvak, P., & Graziano, J. H. (2005). Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environmental Health Perspectives, 113, 1683–1688.PubMedPubMedCentralCrossRef
57.
Catena, C., Colussi, G., Url-Michitsch, M., Nait, F., & Sechi, L. A. (2015). Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension. Journal of the American Society of Hypertension, 9, 167–175.PubMedCrossRef
58.
Ganguly, P., & Alam, S. F. (2015). Role of homocysteine in the development of cardiovascular disease. Nutrition Journal, 14, 1–10.CrossRef
59.
Kolling, J., Scherer, E. B., Da Cunha, A. A., Da Cunha, M. J., & Wyse, A. T. (2011). Homocysteine induces oxidative–nitrative stress in heart of rats: Prevention by folic acid. Cardiovascular Toxicology, 11, 67–73.PubMedCrossRef
60.
Catena, C., Colussi, G., Nait, F., Capobianco, F., & Sechi, L. A. (2015). Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. American Journal of Hypertension, 28, 943–950.PubMedCrossRef
61.
Hoffmann, L., Brauers, G., Gehrmann, T., Häussinger, D., Mayatepek, E., Schliess, F., & Schwahn, B. C. (2013). Osmotic regulation of hepatic betaine metabolism. American Journal of Physiology-Gastrointestinal and Liver Physiology, 304, 835–846.CrossRef
62.
Navik, U., Sheth, V. G., Kabeer, S. W., & Tikoo, K. (2019). Dietary supplementation of methyl donor l-methionine alters epigenetic modification in type 2 diabetes. Molecular Nutrition & Food Research, 63, 1801401.CrossRef
63.
Go, E. K., Jung, K. J., Kim, J. M., Lim, H., Lim, H. K., Yu, B. P., & Chung, H. Y. (2007). Betaine modulates age-related NF-κB by thiol-enhancing action. Biological and Pharmaceutical Bulletin, 30, 2244–2249.PubMedCrossRef
64.
Hasanzadeh-Moghadam, M., Khadem-Ansari, M. H., Farjah, G. H., & Rasmi, Y. (2018). Hepatoprotective effects of betaine on liver damages followed by myocardial infarction. Veterinary Research Forum: An International Quarterly Journal, 9, 129–135.PubMed
65.
Ganesan, B., Buddhan, S., Jeyakumar, R., & Anandan, R. (2009). Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats. Biological Trace Element Research, 131, 278–290.PubMedCrossRef
66.
Barchowsky, A., Dudek, E. J., Treadwell, M. D., & Wetterhahn, K. E. (1996). Arsenic induces oxidant stress and NF-kB activation in cultured aortic endothelial cells. Free Radical Biology and Medicine, 21, 783–790.PubMedCrossRef
67.
Balakumar, P., & Kaur, J. (2009). Arsenic exposure and cardiovascular disorders: An overview. Cardiovascular Toxicology, 9, 169–176.PubMedCrossRef
68.
Patel, D., Yadav, P., Singh, S. K., Tanwar, S. S., Sehrawat, A., Khurana, A., Bhatti, J. S., & Navik, U. (2024). Betaine alleviates doxorubicin-induced nephrotoxicity by preventing oxidative insults, inflammation, and fibrosis through the modulation of Nrf2/HO− 1/NLRP3 and TGF-β expression. Journal of Biochemical and Molecular Toxicology, 38, e23559.PubMedCrossRef
69.
Jiang, Y.-P., Yang, J.-M., Ye, R.-J., Liu, N., Zhang, W.-J., Ma, L., Zheng, P., Niu, J.-G., Liu, P., & Yu, J.-Q. (2019). Protective effects of betaine on diabetic induced disruption of the male mice blood-testis barrier by regulating oxidative stress-mediated p38 MAPK pathways. Biomedicine & Pharmacotherapy, 120, 109474.CrossRef
70.
Go, E. K., Jung, K. J., Kim, J. Y., Yu, B. P., & Chung, H. Y. (2005). Betaine suppresses proinflammatory signaling during aging: The involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinases. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60, 1252–1264.PubMedCrossRef
71.
Khodayar, M., Kalantari, H., Khorsandi, L., Rashno, M., & Zeidooni, L. (2020). Upregulation of Nrf2-related cytoprotective genes expression by acetaminophen-induced acute hepatotoxicity in mice and the protective role of betaine. Human & Experimental Toxicology, 39, 948–959.CrossRef
72.
Urschel, K., & Cicha, I. (2015). TNF-α in the cardiovascular system: From physiology to therapy. International Journal of Interferon, Cytokine and Mediator Research, 7, 9–25.
73.
Gutierrez, S. H., Kuri, M. R., & del Castillo, E. R. (2008). Cardiac role of the transcription factor NF-κB. Cardiovascular & Haematological Disorders-Drug Targets, 8, 153–160.CrossRef
74.
Berthonneche, C., Sulpice, T., Boucher, F., Gouraud, L., De Leiris, J., O’connor, S., Herbert, J.-M., & Janiak, P. (2004). New insights into the pathological role of TNF-α in early cardiac dysfunction and subsequent heart failure after infarction in rats. American Journal of Physiology-Heart and Circulatory Physiology, 287, 340–350.CrossRef
75.
Lau, A., Whitman, S. A., Jaramillo, M. C., & Zhang, D. D. (2013). Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway. Journal of biochemical and molecular toxicology, 27, 99–105.PubMedCrossRef
76.
Zhang, Y., Wei, Z., Liu, W., Wang, J., He, X., Huang, H., Zhang, J., & Yang, Z. (2017). Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway. Oncotarget, 8, 3773.PubMedCrossRef
77.
Nikravesh, M., Mahdavinia, M., Neisi, N., Khorsandi, L., & Khodayar, M. J. (2023). Citicoline ameliorates arsenic-induced hepatotoxicity and diabetes in mice by overexpression of VAMP2, PPAR-γ, As3MT, and SIRT3. Pesticide Biochemistry and Physiology, 192, 105391.PubMedCrossRef
Metadata
Title
Betaine Protects Mice from Cardiotoxicity Triggered by Sodium Arsenite Through Antioxidative and Anti-inflammatory Pathways
Authors
Saeedeh Shariati
Maryam Shirani
Reza Azadnasab
Layasadat Khorsandi
Mohammad Javad Khodayar
Publication date
04-05-2024
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 6/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-024-09864-3

Other articles of this Issue 6/2024

Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway

SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs

USP18 Curbs the Progression of Metabolic Hypertension by Suppressing JAK/STAT Pathway

Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice

  • Open Access
  • Research

Correction: Uncovering the Mechanism of Chinese Hawthorn Leaf on Myocardial Ischemia Based on Network Pharmacology, Molecular Docking Verification, and In Vitro Studies

  • Correction

Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases
Image Credits